Methylprednisolone in COVID-19 Patients (Methyl19LGH)

Clinical trial NCT04559113 · UNKNOWN

Trial details

NCT number: NCT04559113
Sponsor: Lahore General Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

SARS-CoV Infection SARS (Severe Acute Respiratory Syndrome)

Start date: 2020-05-01
Primary completion: 2020-12-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.